During the past decade, DaVita Clinical Research Germany GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DaVita Clinical Research Germany GmbH" are "Chronic Kidney Disease" (2 trials), "Kidney Disease, Chronic" (2 trials), "Chronic Renal Anemia" (1 trials) and "End Stage Renal Disease Requiring Hemodialysis" (1 trials). Many other conditions were trialed in "DaVita Clinical Research Germany GmbH" in a lesser frequency.

Most popular intervention types in "DaVita Clinical Research Germany GmbH" are "Drug" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BAY2976217" (1 trials), "BI 690517" (1 trials), "Darbepoetin Alfa" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "DaVita Clinical Research Germany GmbH" are 6 trials for "All" genders.

Currently, there are NaN active trials in "DaVita Clinical Research Germany GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in DaVita Clinical Research Germany GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in DaVita Clinical Research Germany GmbH, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".